|
Targeting symmetric division in pediatric cancers |
Dana-Farber Cancer Institute |
The Swifty Foundation |
|
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children’s Hospital of Chicago |
Tap Cancer Out |
|
Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis |
Duke University |
Tap Cancer Out |
|
Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease |
St. Jude Children’s Research Hospital |
Northwestern Mutual Foundation |
|
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs |
University of Alberta |
Cure4Cam Childhood Cancer Foundation |
|
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children’s Research Hospital |
Tap Cancer Out |
|
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan |
Flashes of Hope, McKenna Claire Foundation |
|
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan |
Flashes of Hope, McKenna Claire Foundation |
|
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University |
Tap Cancer Out |
|
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope, Tap Cancer Out |
